Details for New Drug Application (NDA): 090194
✉ Email this page to a colleague
The generic ingredient in ROPIVACAINE HYDROCHLORIDE is ropivacaine hydrochloride. There are thirteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ropivacaine hydrochloride profile page.
Summary for 090194
Tradename: | ROPIVACAINE HYDROCHLORIDE |
Applicant: | Hospira |
Ingredient: | ropivacaine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 090194
Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 090194
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 090194 | ANDA | Hospira, Inc. | 0409-9301 | 0409-9301-30 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-9301-30) / 30 mL in 1 VIAL, SINGLE-DOSE (0409-9301-31) |
ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 090194 | ANDA | Hospira, Inc. | 0409-9303 | 0409-9303-20 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-9303-20) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-9303-21) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INJECTION | Strength | 20MG/10ML (2MG/ML) | ||||
Approval Date: | Sep 23, 2014 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INJECTION | Strength | 150MG/30ML (5MG/ML) | ||||
Approval Date: | Sep 23, 2014 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INJECTION | Strength | 150MG/20ML (7.5MG/ML) | ||||
Approval Date: | Sep 23, 2014 | TE: | AP | RLD: | No |
Complete Access Available with Subscription